89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
14.87
+0.02 (0.10%)
Oct 6, 2025, 2:00 PM EDT - Market open
89bio Stock Forecast
Stock Price Forecast
The 8 analysts that cover 89bio stock have a consensus rating of "Buy" and an average price target of $22.31, which forecasts a 50.08% increase in the stock price over the next year. The lowest target is $11 and the highest is $38.
Price Target: $22.31 (+50.08%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for 89bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 3 | 3 | 3 | 2 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 19, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $15 | Strong Buy → Hold | Downgrades | $15 | -2.46% | Sep 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $32 | Strong Buy | Initiates | $32 | +115.27% | Sep 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $30 → $29 | Strong Buy | Maintains | $30 → $29 | +95.09% | Aug 25, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.22
from -3.51
EPS Next Year
-2.36
from -2.22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.05 | -1.83 | |||
| Avg | -2.22 | -2.36 | |||
| Low | -2.30 | -2.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.